Press Releases

NASTAD Announces 2019-2020 Board of Directors

Kyle Taylor

NASTAD Announces 2019-2020 Board of Directors

Washington, DC - Last week, NASTAD, a leading non-partisan non-profit association that represents public health officials who administer HIV and hepatitis programs in the U.S. and around the world, announced its 2019-2020 Board of Directors. NASTAD is governed by a 23-member, elected Board charged with making policy and program decisions on behalf of the full membership.

The 2019-2020 Board of Directors includes:

Officers (Executive Committee)

  • Johanne Morne, New York, Chair
  • Marlene McNeese, Houston, Chair-Elect
  • John Sapero, Arizona, Vice-Chair
  • Michael Kharfen, District of Columbia, Secretary-Treasurer 
  • Jacquelyn Clymore, North Carolina, Immediate Past-Chair (ex-officio, voting)
  • Terrance Moore, Acting Exectuive Director (ex-officio, non-voting)

Board Members

  • Sharon Jordan, Alabama
  • Susan Jones, Alaska
  • Dave Kern, Chicago
  • Laura Reeves, Florida
  • William Lyons, Georgia
  • Peter Whiticar, Hawaii
  • Randy Mayer, Iowa
  • Dawn Fukuda, Massachusetts
  • Kendra Johnson, Mississippi
  • Andrew Gans, New Mexico
  • Demetre Daskalakis, New York City
  • Thomas Bertrand, Rhode Island
  • Tracey Packer, San Francisco
  • Ali Mansaray, South Carolina
  • Shelley Lucas, Texas
  • Hadiyah Charles, U.S. Virgin Islands
  • Beth Crutsinger-Perry, Washington

“It is my pleasure to welcome the 2019-2020 Board of Directors,” said Terrance Moore, NASTAD Acting Executive Director. “I look forward to a productive and eventful year as we work together under the guidance of our Board Chair, Johanne Morne, and her Chair’s Challenge:The Time is NOW: End the Epidemics. This year, we are calling on our members to launch or expand jurisdictional Ending the Epidemic plans, sign on to Undetectable = Untransmittable, and expand PrEP in their jurisdictions.” 

About NASTAD

Founded in 1992, NASTAD is a leading non-partisan non-profit association that represents public health officials who administer HIV and hepatitis programs in the U.S. and around the world. Our singular mission is to end the intersecting epidemics of HIV, viral hepatitis, and related conditions. We do this work by strengthening domestic and global governmental public health through advocacy, capacity building, and social justice.

###

Press Releases